In Short: • The market for RSV therapies could grow to $7.2 billion by 2030. • There were 218 drugs in development for the treatment of RSV in November 2...

The inhalation industry is evolving. Advances in in silico and AI-based technologies, sustainability drivers, and a changing regulatory landscape are collectivel...

Spray Pattern (SP) and Plume Geometry (PG) testing have long been part of U.S. regulatory expectations. They are now explicitly addressed in the 2026 revision of...